Effects of Whole-body Electromyostimulation and Dietary Supplements on "Sarcopenic Obesity"

NCT02356016 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2016-05-23

No results posted yet for this study

Summary

The aim of the study is to determine the effect of whole body electromyostimulation (WB-EMS) and/or nutritional on body composition and functional tasks in elderly females with sarcopenic obesity. Seventy-five, non-sportive, independently living women 70 years and older with Sarcopenic Obesity were randomly assigned to either a WB-EMS group ( n=25), a WB-EMS/nutritional supplements (n=25) or a semi-active control group (an=25). The WB-EMS protocol applied one session of 18 min/week of WB-EMS (bipolar, 85 Hz). Nutritional strategy based on a high protein supplement.

Conditions

  • Sarcopenic Obesity

Interventions

BEHAVIORAL

WB-EMS Intervention

Supervised WB-EMS Intervention 18 min/session (one session/week) and monthly dietary counseling for 6 months

BEHAVIORAL

WB-EMS-Intervention and dietary supplementation

Supervised WB-EMS Intervention and dietary supplementation and monthly dietary counseling for 6 months

OTHER

control (dietary counseling)

Monthly dietary counseling only

Sponsors & Collaborators

  • University of Erlangen-Nürnberg

    collaborator OTHER
  • Bavarian Research Foundation, Munich, Germany

    collaborator UNKNOWN
  • miha bodytec, Gersthofen, Germany

    collaborator UNKNOWN
  • Physiomed, Laipersdorf, Germany

    collaborator UNKNOWN
  • Siemens AG

    collaborator INDUSTRY
  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Cornel Sieber, MD · Institute of Biomedicine of Age, University of Erlangen-Nuremberg

  • Cornelius Bollheimer, MD · Institute of Biomedicine of Age, University of Erlangen-Nuremberg

  • Klaus Engelke, PhD · Institute of Medical Physics, University of Erlangen-Nuremberg

  • Wolfgang Kemmler, PHD · Institute of Medical Physics, University of Erlangen-Nuremberg

  • Ellen Freiberger, PhD · Institute of Biomedicine of Age, University of Erlangen-Nuremberg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02356016 on ClinicalTrials.gov